O
Orgenesis Inc. (ORGS)
PNK – Real Time Price. Currency in USD
0.05
0.00 (0.00%)
At close: Oct 28, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
PNK – Real Time Price. Currency in USD
0.05
0.00 (0.00%)
At close: Oct 28, 2026, 4:00 PM EDT
Orgenesis Inc., a biotech company, focuses on cell and gene therapies in the United States. It operates through two segments: Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare model, POCare network consisting of research institutes and hospitals. Its therapies include autologous; cell-based immunotherapies; and therapeutics for metabolic diseases, anti-viral diseases, and tissue regeneration. It also provides hospital services and cell process development services. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is headquartered in Germantown, Maryland.
| Name | Position |
|---|---|
| Dr. Shimon Hassin Ph.D. | Chief Technology Officer |
| Mr. Douglas Karriker | CFO, Treasurer & Secretary |
| Ms. Vered Caplan M.Sc. | Chairperson of the Board, CEO & President |
| Prof. Sarah Ferber Ph.D. | Founder & Chief Scientific Officer |
| Date | Type | Document |
|---|---|---|
| 2026-06-02 | 8-K | form8-k.htm |
| 2026-05-20 | DEFR14A | formdefr14a.htm |
| 2026-05-05 | DEF 14A | formdef14a.htm |
| 2026-04-16 | PRE 14A | formpre14a.htm |
| 2026-03-26 | 10-K | form10-k.htm |
| 2026-03-13 | 8-K | form8-k.htm |
| 2026-01-26 | 8-K | form8-k.htm |
| 2025-09-16 | 8-K | form8-k.htm |
| 2025-08-25 | 8-K | form8-k.htm |
| 2025-08-19 | 8-K | form8-k.htm |